Get started
Author

Concha Rivas

A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group.
1999 · M A Sanz, G Martín, et al. · PubMed · 411
Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors
2008 · Pau Montesinos, Juan M. Bergua, et al. · Blood · 362
PDF
Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin
2008 · Javier de la Serna, Pau Montesinos, et al. · Blood · 350
Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome
2010 · Miguel A. Sanz, Pau Montesinos, et al. · Blood · 328
Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group
2008 · Miguel A. Sanz, Pau Montesinos, et al. · Blood · 155
Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens
2010 · Pau Montesinos, Chelo Rayón, et al. · Blood · 141
Therapy-Related Myeloid Neoplasms in Patients With Acute Promyelocytic Leukemia Treated With All- Trans -Retinoic Acid and Anthracycline-Based Chemotherapy
2010 · Pau Montesinos, José D. González, et al. · Journal of Clinical Oncology · 75
PDF
Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group
2010 · Martin S. Tallman, Haesook T. Kim, et al. · Blood · 37
Incidence, Outcome and Risk Factors of Pseudotumor Cerebri after All- Trans Retinoic Acid and Anthracycline-Based Chemotherapy in Patients with Acute Promyelocytic Leukemia
2008 · Pau Montesinos, Edo Vellenga, et al. · Blood · 6
Additional Chromosome Abnormalities Have No Prognostic Value in Acute Promyelocytic Leukemia Patients Treated with Simultaneous ATRA and Anthracycline-Based Chemotherapy: An Update of the APL96 and APL99 Pethema Protocols.
2004 · Jose Cervera, Guillermo Martin, et al. · Blood · 6
Treatment of Newly Diagnosed Acute Promyelocytic Leukemia (APL) in the Elderly: A Joint Analysis of the French -Belgian-Swiss and PETHEMA Groups.
2009 · Lionel Ades, Pau Montesinos, et al. · Blood · 5
Microgranular Variant (M3V) of Acute Promyelocytic Leukemia (APL) Does Not Have a Worse Prognosis than Classical APL in the Atra Era: A Report of 153 Patients Treated on Intergroup 0129 and Pethema LPA96 and LPA99.
2004 · Martin S. Tallman, Haesook T. Kim, et al. · Blood · 5
Arsenic Trioxide-Based Therapy Of Relapsed Acute Promyelocytic Leukemia: Updated Results Of The European Registry Of Relapsed APL (PROMYSE)
2013 · Eva Lengfelder, Francesco Lo-Coco, et al. · Blood · 3
Gene Microdeletions in Adult and Pediatric Acute Lymphoblastic Leukemia,
2011 · Inés Gómez-Seguí, Esperanza Such, et al. · Blood · 3
Risk-Adapted Treatment of Acute Promyelocytic Leukemia: Results of the PETHEMA LPA2005 Trial Using All-Trans Retinoic Acid and Anthracycline with Cytarabine for High-Risk Patients
2008 · Miguel A. Sanz, Pau Montesinos, et al. · Blood · 2
Risk-Adapted Treatment of Acute Promyelocytic Leukemia: Updated Results of the Spanish PETHEMA LPA99 Trial Using ATRA and Anthracycline Monochemotherapy.
2007 · Miguel A. Sanz, Pau Montesinos, et al. · Blood · 1
Causes of Induction Failure in Newly Diagnosed Acute Promyelocytic Leukemia Patients Treated with Simultaneous ATRA and Idarubicin (AIDA).
2004 · Javier de la Serna, Guillermo Martin, et al. · Blood · 1
Long-Term Outcome Of 151 Patients With Relapsed APL Receiving Second-Line With Chemotherapy Or Arsenic Trioxide-Based Regimens
2013 · Pau Montesinos, David Martínez-Cuadrón, et al. · Blood
Salvage Therapy with Chemotherapy- or Arsenic Trioxide-Based Regimens for Acute Promyelocytic Leukemia in First Relapse.
2009 · Pau Montesinos, Jordi Esteve, et al. · Blood
Works count: 23
Citation count: 1,891
H-index: 8
I10-index: 8
Year
Topic
Type